Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB
Mandate

Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB

January 13, 2021 Employment and Benefits Corporate Crime & Compliance Real Estate and Construction M&A General Corporate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Göteborg Mark och Betong Entreprenad AB (“GMB”).

GMB is based in Gothenburg and provides construction and contracting services related to infrastructure, foundation and fine planning work as well as both cast-in-place and prefabricated concrete. GMB has a total approximate revenue of SEK 220 million and around 30 employees.

Vinge’s team consisted primarily of partner Christina Kokko and associates Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Frida Ställborn (Real Property & Environment), Tove Lövgren Frisk (Compliance) and Carl Bruneheim (VDR-specialist).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026